AMERANT BAN ($AMTB) posted quarterly earnings results on Wednesday, July 23rd. The company reported earnings of $0.57 per share, beating estimates of $0.40 by $0.17. The company also reported revenue of $110,260,000, beating estimates of $105,442,500 by $4,817,500.
You can see Quiver Quantitative's $AMTB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMERANT BAN Insider Trading Activity
AMERANT BAN insiders have traded $AMTB stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $AMTB stock by insiders over the last 6 months:
- HOWARD A. LEVINE (See remarks) sold 3,628 shares for an estimated $83,580
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMERANT BAN Hedge Fund Activity
We have seen 59 institutional investors add shares of AMERANT BAN stock to their portfolio, and 51 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 426,660 shares (+inf%) to their portfolio in Q1 2025, for an estimated $8,806,262
- KENNEDY CAPITAL MANAGEMENT LLC removed 220,017 shares (-23.5%) from their portfolio in Q1 2025, for an estimated $4,541,150
- CUBIST SYSTEMATIC STRATEGIES, LLC removed 148,765 shares (-79.4%) from their portfolio in Q1 2025, for an estimated $3,070,509
- RHINO INVESTMENT PARTNERS, INC added 133,869 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,763,056
- ENDEAVOUR CAPITAL ADVISORS INC added 126,491 shares (+52.4%) to their portfolio in Q1 2025, for an estimated $2,610,774
- TWO SIGMA ADVISERS, LP added 100,600 shares (+461.5%) to their portfolio in Q1 2025, for an estimated $2,076,384
- TWO SIGMA INVESTMENTS, LP added 88,655 shares (+90.9%) to their portfolio in Q1 2025, for an estimated $1,829,839
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AMERANT BAN Analyst Ratings
Wall Street analysts have issued reports on $AMTB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stephens & Co. issued a "Overweight" rating on 04/29/2025
To track analyst ratings and price targets for AMERANT BAN, check out Quiver Quantitative's $AMTB forecast page.
AMERANT BAN Price Targets
Multiple analysts have issued price targets for $AMTB recently. We have seen 2 analysts offer price targets for $AMTB in the last 6 months, with a median target of $22.0.
Here are some recent targets:
- Russell Gunther from Stephens & Co. set a target price of $24.0 on 04/29/2025
- Wood Lay from Keefe, Bruyette & Woods set a target price of $20.0 on 04/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
